Description

Simple

Clinical

Overview

Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation.

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Fenbufen
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
(R)-warfarin
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with (R)-warfarin.
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with (S)-Warfarin.
1-benzylimidazole
The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Fenbufen.
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Fenbufen.
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of hypertension can be increased when Fenbufen is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Fenbufen.
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with 4-hydroxycoumarin.
4-Methoxyamphetamine
The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Fenbufen.
5-methoxy-N,N-dimethyltryptamine
The risk or severity of hypertension can be increased when Fenbufen is combined with 5-methoxy-N,N-dimethyltryptamine.
Abacavir
Fenbufen may decrease the excretion rate of Abacavir which could result in a higher serum level.
Abciximab
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Abciximab.
Abediterol
The risk or severity of hypertension can be increased when Fenbufen is combined with Abediterol.
Acarbose
Fenbufen may decrease the excretion rate of Acarbose which could result in a higher serum level.
Acebutolol
Fenbufen may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Fenbufen.
Acemetacin
The risk or severity of adverse effects can be increased when Fenbufen is combined with Acemetacin.
Acenocoumarol
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Acenocoumarol.
Acepromazine
The risk or severity of hypertension can be increased when Acepromazine is combined with Fenbufen.
Acetaminophen
The risk or severity of adverse effects can be increased when Acetaminophen is combined with Fenbufen.
Acetohexamide
The protein binding of Acetohexamide can be decreased when combined with Fenbufen.